DBV Technologies (DBVT) Change in Receivables (2020 - 2021)
DBV Technologies (DBVT) posted quarterly Change in Receivables of $24000.0 for Q4 2021, down 75.0% year-on-year from $96000.0 in Q4 2020, and up 2300.0% on a QoQ basis from $1000.0 in Q3 2021.
DBV Technologies (DBVT) Change in Receivables (2020 - 2021) Analysis & Trends
DBV Technologies (DBVT) has reported Change in Receivables for 2 consecutive years, with $24000.0 the latest figure, recorded in Q4 2021.
- Quarterly Change in Receivables fell 75.0% year-over-year to $24000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $24000.0 (up 101.15% YoY) and the FY2021 annual result came in at -$2.2 million, down 203.86% from the prior year.
- Change in Receivables improved to $24000.0 in Q4 2021 per DBVT's latest filing, from $1000.0 in the prior quarter.
- Over the last five years, Change in Receivables for DBVT reached as high as $2.0 million in Q3 2020 and fell as low as -$2.1 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 24,000.00 |
| Dec 31, 2021 | 24,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2021 | -74,000.00 |
| Jun 30, 2021 | -74,000.00 |
| Mar 31, 2021 | -2.10 Mn |
| Mar 31, 2021 | -2.10 Mn |
| Dec 31, 2020 | 96,000.00 |
| Dec 31, 2020 | 96,000.00 |
| Sep 30, 2020 | 1.98 Mn |
| Sep 30, 2020 | 1.98 Mn |